Impact of radiological and pathological splenic vein involvement in patients with resectable pancreatic body or tail cancer-Reference-Cited by-同舟云学术

Impact of radiological and pathological splenic vein involvement in patients with resectable pancreatic body or tail cancer

Published:2024-01-15 Issue:1 Volume:409 Page:
ISSN:1435-2451
Container-title:Langenbeck's Archives of Surgery
language:en
Short-container-title:Langenbecks Arch Surg

Author:

Kuriyama Naohisa^ORCID,Mizuno Shugo,Sakamoto Tatsuya,Fujimura Yu,Yuge Takuya,Noguchi Daisuke,Ito Takahiro,Hayasaki Aoi,Fujii Takehiro,Iizawa Yusuke,Murata Yasuhiro,Tanemura Akihiro,Nagata Motonori,Usui Miki,Kishiwada Masashi

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00423-024-03232-z.pdf

Reference34 articles.

1. Rawla P, Sunkara T, Gaduputi V (2019) Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 10:10–27. https://doi.org/10.14740/wjon1166

2. NCCN Guideline, V2.2022 [internet] (2022) Pancreatic Adenocarcinoma. https://www.nccn.org/guidlines/category_1, 2022. Accessed 26 June 2007

3. Isaji S, Mizuno S, Windsor JA et al (2018) International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 18:2–11. https://doi.org/10.1016/j.pan.2017.11.011

4. Fujita T, Nakagohri T, Gotohda N et al (2010) Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas 39:e48-54. https://doi.org/10.1097/MPA.0b013e3181bd5cfa

5. Gantois D, Guilbaud T, Scemama U et al (2022) Prognostic impact of splenic vessel involvement and tumour size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study. Langenbecks Arch Surg 407:153–165. https://doi.org/10.1007/s00423-021-02291-w